Cell Therapy Market Report 2026

Cell Therapy Market Overview

• Cell Therapy market size has reached to $16.87 billion in 2025 • Expected to grow to $32.48 billion in 2030 at a compound annual growth rate (CAGR) of 13.9% • Growth Driver: The Soaring Prevalence Of Chronic Diseases Fuels Expansion In The Cell Therapy Market • Market Trend: Dual-Targeting CAR T Innovations Advancing Outcomes In Refractory B-Cell Malignancies • North America was the largest region in 2025.

What Is Covered Under Cell Therapy Market?

Cell therapy refers to the replacement or repair of damaged tissue and/or cells through the transplantation of human cells. Numerous different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders with the help of new technologies, inventive products, and infinite imagination. It is a form of treatment wherein a patient receives live cells via injection, grafting, or implant in order to produce a therapeutic result. The main techniques used in cell therapy are stem cell therapy, cell vaccines, adoptive cell transfer (ACT), fibroblast cell therapy, and chondrocyte cell therapy. Stem cell treatment, also known as regenerative medicine, uses stem cells or their derivatives to stimulate the healing response of sick, defective, or wounded tissue. The different types of therapies include allogeneic therapies, and autologous therapies and are used in various applications such as oncology, cardiovascular disease (CVD), orthopedics, wound healing, and others.

What Is The Cell Therapy Market Growth Forecast?

The cell therapy market size is expected to see rapid growth in the next few years. It will grow to $32.48 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in gene editing, automation in cell manufacturing, growing investment in cell therapy startups, increasing demand for regenerative medicine, expanding application across oncology and cvd. Major trends in the forecast period include personalized cell therapy development, allogeneic therapy advancements, improved cell storage & transportation, regulatory & compliance innovations, emerging clinical applications.

Global Cell Therapy Market Segmentation

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy 2) By Therapy Type: Allogeneic Therapies, Autologous Therapies 3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications Subsegments: 1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy 2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine 3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy 4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy 5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Is The Driver Of The Cell Therapy Market?

The rising prevalence of chronic diseases aided the expansion of the cell therapy market. According to the US Centers for Disease Control and Prevention (CDC), chronic disease is a condition that lasts for one year or more, requires medical attention, limits daily activities, or both, and includes heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells can benefit patients suffering from spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, significant updates were released regarding public health initiatives. Every year, over 944,800 Americans die from heart disease or stroke, accounting for more than one-third of all deaths. In the U.S., 1.7 million individuals are diagnosed with cancer annually, with over 600,000 fatalities, making it the second leading cause of death. Additionally, more than 38 million Americans have diabetes, while another 98 million adults are prediabetic, increasing their risk for type 2 diabetes. Diabetes can lead to severe complications like heart disease, kidney failure, and blindness. Obesity affects 20% of children and 42% of adults, heightening the risk of chronic diseases such as type 2 diabetes, heart disease, and certain cancers. The growing prevalence of chronic diseases increased the demand for cell therapies and contributed to the growth of the cell therapy industry.

Key Players In The Global Cell Therapy Market

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

Global Cell Therapy Market Trends and Insights

Major companies operating in the cell therapy market are developing next-generation, multi-targeted therapies supported by strong early-stage clinical data to enhance treatment effectiveness and address unmet needs in complex cancers. For instance, in June 2025, Johnson & Johnson, a US-based pharmaceutical company, has reported promising first results from its Phase 1b study of JNJ-4496, a dual-targeting CAR T-cell therapy designed to bind both CD19 and CD20 in relapsed or refractory large B-cell lymphoma. Early data presented at the 2025 EHA Congress show strong response rates, with 75–80% complete responses at the recommended Phase 2 dose and no Grade 3–4 cytokine release syndrome. The therapy demonstrated encouraging safety, manageable neurotoxicity, and robust activity even in heavily pretreated patients. These findings highlight the potential of next-generation dual-targeting CAR T approaches and reinforce Johnson & Johnson’s commitment to advancing innovative treatments for B-cell malignancies.

What Are Latest Mergers And Acquisitions In The Cell Therapy Market?

In August 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Sigilon Therapeutics for $34.6 million. With this acquisition, Lilly aims to enhance its research and development efforts in encapsulated cell therapies, specifically targeting Type 1 diabetes with its lead candidate, SIG-002. This move will strengthen Lilly's position in the diabetes treatment market. Sigilon Therapeutics is a US-based biotechnology company focused on developing innovative cell therapies.

Regional Insights

North America was the largest region in the cell therapy market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Therapy Market?

The cell therapy market includes revenues earned by entities by enhancing the growth of new healthy skin tissue and enhancing collagen production. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Therapy Market Report 2026?

The cell therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.